Kidney transplantation
Hello Professor Lin, I would like to ask you a question.
Recently, I read online that individuals with hepatitis B should avoid kidney transplantation.
Is this true? Why is it not advisable? What side effects could occur if they undergo the procedure? Would the transplant be successful? I asked my doctor, and they mentioned that it is due to the need for immunosuppressive medication post-transplant.
Is this accurate? I apologize for bothering you with my questions.
Thank you.
jacky, 20~29 year old female. Ask Date: 2005/06/17
Dr. Lin Qingyuan reply Rare Disease
In patients with abnormal liver function, the use of immunosuppressive drugs after liver transplantation may activate the hepatitis B virus, potentially leading to active hepatitis.
More concerning is the risk of fulminant hepatitis, which can be fatal.
Therefore, while the surgery itself may not pose issues, the complications can be life-threatening.
Reply Date: 2005/06/17
More Info
When considering kidney transplantation for patients with Hepatitis B (HBV), there are several important factors to take into account. Hepatitis B is a viral infection that primarily affects the liver, but it can have significant implications for kidney health and the overall success of transplantation.
Firstly, it is crucial to understand that patients with chronic Hepatitis B are at risk for liver complications, especially when they undergo immunosuppressive therapy, which is necessary after a kidney transplant to prevent organ rejection. The use of immunosuppressive medications can lead to reactivation of the Hepatitis B virus, potentially resulting in acute liver failure or fulminant hepatitis, which can be life-threatening. This is particularly concerning for patients who have not been adequately treated for their Hepatitis B prior to transplantation.
The concern about kidney transplantation in patients with Hepatitis B stems from the potential for viral reactivation. If a patient has active Hepatitis B, the immunosuppressive therapy can allow the virus to multiply unchecked, leading to severe liver damage. This is why it is often recommended that patients with chronic Hepatitis B be treated with antiviral medications, such as tenofovir or entecavir, prior to undergoing a kidney transplant. These medications can help suppress the virus and reduce the risk of reactivation during the post-transplant period.
In terms of success rates, kidney transplantation can still be successful in patients with Hepatitis B, provided that the virus is well-managed. Studies have shown that with proper antiviral therapy, the outcomes for kidney transplant recipients with Hepatitis B can be comparable to those without the virus. However, the key is to ensure that the Hepatitis B is under control before the transplant and that the patient is closely monitored afterward.
Additionally, it is important to note that the choice of immunosuppressive regimen may need to be adjusted for patients with Hepatitis B. Some immunosuppressants may have a higher risk of causing liver issues in these patients, so a careful selection of medications is essential.
In summary, while there are risks associated with kidney transplantation in patients with Hepatitis B, it is not an absolute contraindication. With appropriate antiviral therapy and careful management, many patients can successfully undergo transplantation. It is crucial for patients to have thorough discussions with their healthcare providers about their specific situation, including the status of their Hepatitis B, the potential risks of reactivation, and the best strategies for managing their health before and after the transplant. This collaborative approach will help ensure the best possible outcomes for kidney transplant recipients with Hepatitis B.
Similar Q&A
Navigating Treatment Options for Liver Fibrosis in Kidney Transplant Patients
Dear Dr. Chen, I am a kidney transplant recipient and a hepatitis C patient, currently 57 years old. Eight years ago, I underwent a successful kidney transplant surgery in mainland China, and since then, my post-operative condition has been good, with all indices normal (Cr: 0.8...
Dr. Chen Shidian reply Gastroenterology and Hepatology
Mr. Andy: 1. Hepatitis C should be ruled out or treated before kidney transplantation. 2. In Taiwan, modern blood transfusions are filtered for Hepatitis C from donors. 3. It is indeed challenging to manage, and a biopsy is necessary for evaluation. The Department of Hepatobiliar...[Read More] Navigating Treatment Options for Liver Fibrosis in Kidney Transplant Patients
Understanding Kidney Issues in Hepatitis B Patients: What to Monitor?
Hello, I am a hepatitis B patient currently on regular medication for hepatitis B. In my recent health check-up, my urine albumin was 22, creatinine was 1.26, white blood cell count was 11,030, and neutrophils were 77.5%. The doctor did not provide any recommendations, only menti...
Dr. Hu Guozheng reply Gastroenterology and Hepatology
Chronic hepatitis B requires long-term treatment and regular monitoring. It is advisable to consult your attending physician. Thank you.[Read More] Understanding Kidney Issues in Hepatitis B Patients: What to Monitor?
Understanding Complications After Kidney Transplant: A Guide for Patients
Hello Dr. Fang, I would like to ask you a question. My mother is 42 years old (she has hepatitis B). In February 2004, she fainted and was diagnosed with chronic kidney failure at Chang Gung Memorial Hospital in Taipei. Last July, she underwent a kidney transplant at Taichung Ve...
Dr. Chen Zhiping reply Gastroenterology and Hepatology
Hello, jaundice, thrombocytopenia, and edema are symptoms that may raise concerns about the possibility of cirrhosis. Therefore, it would be advisable for your mother's physician to consult a hepatologist for an evaluation to determine if there is chronic hepatitis, signific...[Read More] Understanding Complications After Kidney Transplant: A Guide for Patients
Managing Hepatitis B and Membranous Nephropathy: Treatment Insights
Hello, I have been a carrier of Hepatitis B for over ten years, and for the past year, I have been troubled by membranous nephropathy (as confirmed by biopsy). My lab results are as follows: total cholesterol: 268, BUN: 15.5, creatinine: 1.0, uric acid: 6.3, AST: 46, ALT: 52, alb...
Dr. Yang Guojun reply Gastroenterology and Hepatology
In your case, there are two possibilities. First, you may have two conditions, specifically both hepatitis B and nephritis, which is a relatively common scenario. The second possibility is that your nephritis is being affected by hepatitis B. In this situation, treating hepatitis...[Read More] Managing Hepatitis B and Membranous Nephropathy: Treatment Insights
Related FAQ
Rare Disease Treatment
(Rare Disease)
Other(Rare Disease)
Wilson'S Disease(Rare Disease)
Kawasaki Disease(Rare Disease)
Congenital Metabolic Disorders(Rare Disease)
Whole Exome Sequencing(Rare Disease)
Height(Rare Disease)
Newborn Screening(Rare Disease)
Ichthyosis(Rare Disease)
G6Pd Deficiency(Rare Disease)